{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:35Z","timestamp":1772165675124,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10456-x","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T08:21:40Z","timestamp":1737102100000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors of progression to severity and death in COVID-19 patients at two health care sites in Bamako, Mali"],"prefix":"10.1186","volume":"25","author":[{"given":"Abdoulaye Mamadou","family":"Traore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamadou Karim","family":"Toure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaya Ibrahim","family":"Coulibaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Modibo","family":"Keita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bakary","family":"Diarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salif","family":"Sanafo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garan","family":"Dabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoudou","family":"Kodio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bourama","family":"Traore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aminata","family":"Diarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adama","family":"Dicko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamar A.","family":"Traore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ousmane","family":"Faye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daouda K.","family":"Minta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"10456_CR1","volume-title":"Novel coronavirus(2019-nCoV): situation report 1","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Novel coronavirus(2019-nCoV): situation report 1. Geneva: WHO; 2020."},{"issue":"4","key":"10456_CR2","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","volume":"5","author":"AE Gorbalenya","year":"2020","unstructured":"Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536\u201344.","journal-title":"Nat Microbiol"},{"issue":"5","key":"10456_CR3","doi-asserted-by":"publisher","first-page":"200131e","DOI":"10.2807\/1560-7917.ES.2020.25.5.200131e","volume":"25","author":"Eurosurveillance Editorial Team","year":"2020","unstructured":"Eurosurveillance Editorial Team. Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern. Euro Surveil. 2020;25(5):200131e.","journal-title":"Euro Surveil"},{"issue":"1","key":"10456_CR4","first-page":"157","volume":"91","author":"D Cucinotta","year":"2020","unstructured":"Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157\u201360.","journal-title":"Acta Biomed"},{"key":"10456_CR5","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard. https:\/\/covid19.who.int\/. Consulted on November 19, 2022 at 2:53 p.m."},{"key":"10456_CR6","doi-asserted-by":"publisher","unstructured":"Itai C, Mathias D, Mbuzeleni H, Tafadzwa D. COVID-19: Unpacking the low number of cases in Africa, Public Health Pract (Oxf) 2020 Nov:1:100038. https:\/\/doi.org\/10.1016\/j.puhip.2020.100038. Epub 2020 Dec 22.","DOI":"10.1016\/j.puhip.2020.100038"},{"issue":"7","key":"10456_CR7","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.acra.2020.04.033","volume":"27","author":"S Wan","year":"2020","unstructured":"Wan S, Li M, Ye Z, Yang C, Cai Q, Duan S, et al. CT manifestations and clinical characteristics of 1115 patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Acad Radiol. 2020;27(7):910\u201321.","journal-title":"Acad Radiol"},{"key":"10456_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijid.2021.05.024","volume":"108","author":"M Jaspard","year":"2021","unstructured":"Jaspard M, Sow MS, Juchet S, Diendere E, Serra B, Kojan R, et al. Clinical presentation, outcomes and factors associated with mortality: a prospective study from three COVID-19 referral care centres in West Africa. Int J Infect Dis. 2021;108:45\u201352.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"10456_CR9","doi-asserted-by":"publisher","first-page":"105938","DOI":"10.1016\/j.ijantimicag.2020.105938","volume":"55","author":"CA Devaux","year":"2020","unstructured":"Devaux CA, Rolain JM, Colson P, Didier R. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020;55(5):105938.","journal-title":"Int J Antimicrob Agents"},{"key":"10456_CR10","first-page":"1","volume":"3","author":"DR Boulware","year":"2020","unstructured":"Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med. 2020;3:1\u20139.","journal-title":"N Engl J Med"},{"key":"10456_CR11","doi-asserted-by":"publisher","first-page":"104786","DOI":"10.1016\/j.antiviral.2020.104786","volume":"178","author":"KT Choy","year":"2020","unstructured":"Choy KT, Wong AYL, Kaewpreedee P, Sia SF, Chen D, Hui KPY, et al. Remdesivir, lopinavir, ivermetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antiviral Res. 2020;178:104786.","journal-title":"Antiviral Res"},{"key":"10456_CR12","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the treatment of Covid-19 - preliminary report. N Engl J Med. 2020;383:992\u20134.","journal-title":"N Engl J Med"},{"key":"10456_CR13","doi-asserted-by":"publisher","first-page":"858693","DOI":"10.3389\/fphar.2022.858693","volume":"13","author":"S Yang","year":"2022","unstructured":"Yang S, Shen S, Hou N. Is ivermectin effective in treating COVID-19? Front Pharmacol. 2022;13:858693.","journal-title":"Front Pharmacol"},{"key":"10456_CR14","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00134-021-06448-5","volume":"47","author":"YM Arabi","year":"2021","unstructured":"Arabi YM, Gordon AC, Derde LPG, Nichol AD, Murthy S, Beidh FA, et al. Lopinavir\/ritonavir and hydroxychloroquine for critically ill patients with COVID-19 REMAP-CAP randomized controlled trial. Intensive Care Med. 2021;47:867\u201386.","journal-title":"Intensive Care Med"},{"issue":"1","key":"10456_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1080\/07853890.2022.2034936","volume":"54","author":"W Wen","year":"2022","unstructured":"Wen W, Chen C, Tang J, Wang C, Zhou M, Cheng Y, et al. Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and paxlovid) for COVID-19: a meta-analysis. Ann Med. 2022;54(1):516\u201323.","journal-title":"Ann Med"},{"key":"10456_CR16","volume-title":"Modern epidemiology","author":"KJ Rothman","year":"2008","unstructured":"Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.","edition":"3"},{"key":"10456_CR17","volume-title":"Applied logistic regression","author":"DW Hosmer","year":"2007","unstructured":"Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley-Interscience; 2007."},{"key":"10456_CR18","doi-asserted-by":"crossref","unstructured":"Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci AM et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. PLoS Med. 2020:17e1003346.","DOI":"10.1371\/journal.pmed.1003346"},{"issue":"10223","key":"10456_CR19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"Lancet"},{"key":"10456_CR20","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708\u201320.","journal-title":"N Engl J Med"},{"issue":"7","key":"10456_CR21","doi-asserted-by":"publisher","first-page":"e2005","DOI":"10.1093\/cid\/ciaa1198","volume":"73","author":"Western Cape Department of Health in collaboration with the National Institute for Communicable Diseases, South Africa","year":"2021","unstructured":"Western Cape Department of Health in collaboration with the National Institute for Communicable Diseases, South Africa. Risk factors for coronavirus disease 2019 (COVID-19) death in a population cohort study from the Western Cape Province, South Africa. Clin Infect Disease. 2021;73(7):e2005\u201315.","journal-title":"Clin Infect Disease"},{"key":"10456_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12016-022-08921-5","volume":"64","author":"JJ Zhang","year":"2023","unstructured":"Zhang JJ, Dong X, Liu GH, Gao YD. Risk and protective factors for COVID-19 morbidity, severity, and mortality. Clin Rev Allergy Immunol. 2023;64:90\u2013107.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"125","key":"10456_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.npg.2021.06.002","volume":"21","author":"M Muller","year":"2021","unstructured":"Muller M, Bulubas I, Vogel T. Les facteurs pronostiques dans la COVID-19. Npg G\u00e9riatrie. 2021;21(125):304\u201312.","journal-title":"Npg G\u00e9riatrie"},{"key":"10456_CR24","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12879-021-05992-1","volume":"21","author":"M Flook","year":"2021","unstructured":"Flook M, Jackson C, Vasileiou E, Simpson CR, Muckian MD, Agrawal U, et al. Informing the public health response to COVID-19: a systematic review of risk factors for disease, severity, and mortality. BMC Infect Dis. 2021;21:342.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10456_CR25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.coi.2010.05.003","volume":"22","author":"AC Shaw","year":"2010","unstructured":"Shaw AC, Joshi S, Greenwood H, Panda A, Lord JM. Aging of the innate immune system. Curr Opin Immunol. 2010;22(4):507\u201313.","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"10456_CR26","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/all.14657","volume":"76","author":"YD Gao","year":"2021","unstructured":"Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. 2021;76(2):428\u201355.","journal-title":"Allergy"},{"issue":"1","key":"10456_CR27","doi-asserted-by":"publisher","first-page":"e044640","DOI":"10.1136\/bmjopen-2020-044640","volume":"11","author":"BG Pijls","year":"2021","unstructured":"Pijls BG, Jolani S, Atherley A, Derckx RT, Dijkstra JIR, Franssen GHL, et al. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies. BMJ Open. 2021;11(1):e044640.","journal-title":"BMJ Open"},{"issue":"9","key":"10456_CR28","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.rmed.2007.04.011","volume":"101","author":"ME Falagas","year":"2007","unstructured":"Falagas ME, Mourtzoukou EG, Vardakas KZ. Sex differences in the incidence and severity of respiratory tract infections. Respir Med. 2007;101(9):1845\u201363.","journal-title":"Respir Med"},{"issue":"7","key":"10456_CR29","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1111\/all.14309","volume":"75","author":"Q Cai","year":"2020","unstructured":"Cai Q, Huang D, Ou P, Yu H, Zhu Z, Xia Z, et al. COVID-19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy. 2020;75(7):1742\u201352.","journal-title":"Allergy"},{"key":"10456_CR30","doi-asserted-by":"crossref","unstructured":"Wan S, Xiang Y, Fang W, Zheng Y, Li B, Hu Y et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol. 2020;92(7):797\u2013806.","DOI":"10.1002\/jmv.25783"},{"issue":"11","key":"10456_CR31","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061\u20139.","journal-title":"JAMA"},{"issue":"3","key":"10456_CR32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","volume":"21","author":"W Liang","year":"2020","unstructured":"Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARSCoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335\u20137.","journal-title":"Lancet Oncol"},{"issue":"5","key":"10456_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1159\/000507471","volume":"51","author":"L Wang","year":"2020","unstructured":"Wang L, Li X, Chen H, Yan S, Li D, Li Y. Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from Wuhan, China. Am J Nephrol. 2020;51(5):343\u20138.","journal-title":"Am J Nephrol"},{"issue":"1","key":"10456_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12185-020-03029-y","volume":"113","author":"H Asakura","year":"2021","unstructured":"Asakura H, Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Intl J Hematol. 2021;113(1):45\u201357.","journal-title":"intl J Hematol"},{"issue":"10229","key":"10456_CR35","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"issue":"10239","key":"10456_CR36","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/S0140-6736(20)31189-2","volume":"395","author":"MJ Cummings","year":"2020","unstructured":"Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395(10239):1763\u201370.","journal-title":"Lancet"},{"issue":"5","key":"10456_CR37","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneuminia in Wuhan China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475\u201381.","journal-title":"Lancet Respir Med"},{"issue":"20","key":"10456_CR38","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052\u20139.","journal-title":"JAMA"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10456-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10456-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10456-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T08:21:46Z","timestamp":1737102106000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10456-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10456"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10456-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3099856\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"assertion":[{"value":"23 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is an observational study based on routine data. We obtained the approval of the Medical Committee of the hospital and the one of Pasteur Polyclinic. The patient or his\/her legal guardian was informed that the data would be published anonymously.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}